Maine Medicine Weekly Update - 12/11/2017  (Plain Text Version)

Return to Graphical Version

 

In this issue:
IN THE SPOTLIGHT
•  MMA Legislative Committee Meets to Prepare for Next Legislative Session
•  Online Links to Opioid CME
•  Congressional Stopgap Spending Plan Fails to Include CHIP 2018 Funding
•  Health Insurance Marketplace 2018: Open Enrollment Ends Friday
•  New AMA, CMS Resources Aid Transition to the New Medicare Card
•  Sanofi Genzyme: Arthritis Medication Should Not Be Used Due To Side Effects
•  Maine CDC Message on Immunizations
•  Naloxone Research Shows Importance of Post-Administration Intervention
•  Opportunities for Year-End Giving at MMA
•  Improving Opioid Prescribing and Patient Safety: Monday, 12/18 at EMMC
•  Peer Navigation Program from Facing Our Risk of Cancer Empowered
128TH MAINE LEGISLATURE
•  Legislative Calls to Resume When Legislature Returns
•  Highlights of Recently Enacted Legislation: L.D. 911 (c. 267) Prohibiting Gifts to Practitioners from Sellers
UPCOMING EVENTS
•  Online Learning Opportunities Offering CME Credits - from the Northern New England Practice Transformation Network
•  New Free CME on Alzheimer's Risk, Detection, and Management
•  Webinar on Improving Opioid Prescribing and Patient Safety: Wednesday, December 13
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Chief Executive Officer - Pines Health Services
•  Clinical Cardiology Opportunity
•  Family Medicine Physician/Clinician Leader
•  BE/BC Family Practitioner - Lewiston, ME
•  Primary Care Physician - Eastern Maine Medical Center
•  Relocate to Beautiful Southwestern Maine - Medical Director/Family Practice Physician
•  Palliative Care Provider
•  Gastroenterologist - Brunswick, ME
•  Hospitalist - Brunswick, ME
•  DO or MD Physician - Augusta, ME
•  Outpatient Only - Internal Medicine with Loan Repayment & Sign-on Bonus
•  Physiatrist - Brunswick, Maine
•  Opportunities at the VA for Volunteer Physicians

 

Naloxone Research Shows Importance of Post-Administration Intervention

See information about a naloxone study published in the Annals of Emergency Medicine.


More than 84 percent of Massachusetts patients who received naloxone from emergency medical services were alive one year following the administration. The study abstract, published in the Annals of Emergency Medicine, reviewed data from more than 12,000 naloxone administrations between July, 1, 2013, and Dec. 31, 2015. The study's authors concluded that, among other things: "Patients who survive opioid overdose should be considered extremely high risk and should receive interventions such as offering buprenorphine, counseling and referral to treatment prior to [emergency department] discharge."

Read more about naloxone on the AMA opioid microsite.